VP Global Asset Lead

## VP Global Asset LeadApply: Paris: Full time: Posted Today: End Date: December 31, 2026 (30+ days left to apply): R-22779Title:VP Global Asset LeadCompany:Ipsen Pharma (SAS)About Ipsen:Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.
S., France and the U.
K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and societyFor more information, visit us at https://www.ipsen.com/and follow our latest news on LinkedIn and Instagram.

Job Description
VP Global Asset Lead CorabotaseDivision / Function:NeuroscienceManager's Job Title:EVP, Neuroscience & AestheticsIpsen Job Profile:Asset Lead

Location:
Paris, or LondonWHAT
- Summary & Purpose of the PositionThe VP Global Asset Lead, Corabotase Tx is the single global enterprise owner for Corabotase Therapeutics, accountable for shaping and delivering the integrated asset strategy across migraine, spasticity, cervical dystonia and future therapeutic opportunities. The role is responsible for moving Corabotase Tx from current proof-of-concept and Phase 2/Phase 3 planning through PFR investment decisions, pivotal development, regulatory strategy, access readiness, and global launch preparation.
This role carries a strong enterprise, development and commercial bias. The Asset Lead must build the investment case for Corabotase Tx, define where Ipsen should play, determine how Ipsen can win, and ensure the asset is not assessed in isolation but as part of the broader Neuroscience franchise alongside Dysport, migraine infrastructure, Ax-Tx pricing considerations and portfolio-level value creation. Main Responsibilities & Technical Competencies1. Own the integrated global Corabotase Tx asset strategyLead one coherent global strategy for Corabotase Tx across all prioritised therapeutic indications, translating the asset vision into an integrated cross-functional plan with clear development, regulatory, medical, access, commercial, manufacturing, financial and governance priorities.* Own the global Corabotase Tx strategy and value creation plan across priority therapeutic indications.
* Define the role of Corabotase within the broader Neuroscience franchise, including its relationship with Dysport and future portfolio opportunities.
* Translate the asset ambition into clear enterprise choices on indication prioritisation, development sequencing, investment allocation and launch readiness. 2. Drive development strategy, PFR readiness and stage-gate decision-makingEnsure Corabotase Tx progresses through development and governance with the level of evidence, clarity and strategic discipline required for major investment decisions.* Lead the integrated development strategy from proof-of-concept through pivotal development, filing and launch preparation.
* Define indication-specific development pathways, investment requirements, probability of success and value creation opportunities.
* Deliver decision-ready recommendations and governance materials for PFR, senior leadership and Board review. 3. Define indication prioritisation, sequencing and value propositionLead the strategic choices on which therapeutic indications Corabotase Tx should pursue, in which order, and with what differentiated value proposition.* Own indication prioritisation and sequencing across therapeutic opportunities to maximise long-term enterprise value.
* Define differentiated value propositions grounded in patient needs, customer insights, market dynamics and access realities.
* Ensure strategic choices are based on realistic value capture and competitive advantage rather than theoretical market potential alone. 4. Build the US-first commercial, access and forecasting strategyOwn the global commercial strategy for Corabotase Tx, with particular focus on the U.
S. as the largest value driver and the market where adoption, access and economics will determine success.* Lead long-range forecasting, commercial strategy and launch readiness planning across priority markets.
* Define realistic value capture scenarios and the capabilities, investments and partnerships required to deliver them.
* Ensure commercial strategies are grounded in robust customer, payer, provider and competitive insights. **5. Manage portfolio interactions with Dysport and Co